In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 583 for your search:
Drug:  melphalan
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase IV, Phase III
Type: Treatment
Status: Unknown
Age: 21 and under
Sponsor: Other
Protocol IDs: GPOH-NB2004, EU-20661, NCT00410631

2.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: 20050100, NCT00352703

3.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: SHEBA-06-4196-MKM-CTIL, NCT00449592

4.

Phase: Phase IV
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: TaCyDexVMP7, NCT00652041

5.

Phase: Phase IV
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 2006-00055-18, NCT00415103

6.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-MBDT-7814

7.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 4 to 70
Sponsor: Other
Protocol IDs: CDR0000066968, RP 98-15, RPCI-RP-9815, NCI-V99-1527, NCT00003816

8.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: DFCI-75118

9.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 18 to 69
Sponsor:
Protocol IDs: WCCC-CO-8111, NCI-D81-048-515

10.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 20 and over
Sponsor:
Protocol IDs: SAFR-CT-MM-2

11.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: EST-5274, MAYO-706031

12.

Phase: Phase III, Phase II
Type: Treatment
Status: Closed
Age: 0 to 18
Sponsor: NCI
Protocol IDs: CCG-3891

13.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: Under 30
Sponsor: NCI, Other
Protocol IDs: AHOD0121, CDR0000330135, COG-AHOD0121, NCT00070187

14.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: UARK 2003-26, NCT00090493

15.

Phase: Phase III, Phase II
Type: Treatment
Status: Completed
Age: 19 and over
Sponsor: Other
Protocol IDs: 01-002-0601, NCT00205751

16.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Unknown
Age: Any age
Sponsor: Other
Protocol IDs: UHW-AML16, EU-20677, ISRCTN11036523, EUDRACT-2005-002846-14, MREC-CU106, NCT00454480

17.

Phase: Phase III, Phase II
Type: Diagnostic, Treatment
Status: Closed
Age: 18 to 65
Sponsor: Other
Protocol IDs: R08096M, 2008-003936-38, 26866138MMY2063, NCT00861250

18.

Phase: Phase III, Phase II
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Closed
Age: Any Age
Sponsor: Pharmaceutical / Industry
Protocol IDs: CDX-353-002, NCT01660633

19.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 70
Sponsor:
Protocol IDs: MRC-ME01, EU-94025

20.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 65
Sponsor:
Protocol IDs: MRC-LEUK-MYEL-VII, EU-94030, NCT00002599

21.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 65 to 74
Sponsor: Other
Protocol IDs: MRC-LEUK-MYEL-VIII, EU-94031, NCT00002653

22.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 21
Sponsor:
Protocol IDs: GER-NB90, EU-96004, NCT00002802

23.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 65
Sponsor: NCI
Protocol IDs: E-2493, E2493

24.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 15 to 59
Sponsor: NCI, Other
Protocol IDs: MDA DM95-121, P30CA016672, NCI-V96-1010, CDR0000065044, NCT00002835

25.

Phase: Phase III
Type: Treatment
Status: Closed
Age: under 60
Sponsor:
Protocol IDs: FRE-FNCLCC-PEGASE04, EU-96033
1     
New Search